Trialkey (ASX: OPL)

TrialKey is proud to be participating in the ARCS Annual Conference on June 4th at ICC Sydney as part of the expert panel discussion, “AI in Action: Bridging Innovation and Practicality in Clinical Trials.”
#ARCS2025 #asx #biotech #opyl #trialkey #clinicaltrials #medicalresearch #drugdiscovery

Thank you for joining our “Enhancing Clinical Trials From Strategy to Execution” webinar, cohosted by Opyl, and Biointelect.
​
Watch the recording: youtu.be/MaGyugFMsfI
Book a TrialKey consultation: appt.link/minhthu
​
#CRO #saas #aisaas #biotech #clinicaltrials #ai #biotechnews #aitrends

Opyl is attending BIO Korea 2025 (7–9 May, Seoul) as part of the Australian delegation. Dr Minh-Thu Cao Xuan will represent Opyl and showcase TrialKey.
Connect via the BIO Korea 2025 partnering platform

#BIOKorea #BIOkorea2025 #biotech #asx #aiinhealthcare #biotechnews

Introducing: The AI Biotech Fund, a wholesale only innovative investment vehicle focused on generating significant capital appreciation by leveraging advanced AI-driven strategies. Open to wholesale investors only. Enquire now: aibiotechfund.com

#asx #nasdaq #nyse #cboe #biotechinvesting

Join Avion and Opyl in our upcoming webinar ‘Streamlining Clinical Trial Start-Up’
REGISTER NOW!
www.linkedin.com/events/strea...
​
​#CRO #AI #pharma #trialstartup #saas #clinicaltrialsaas #aisaas #medicalresearch #feasibility

It’s Day 1 of BIO Europe Spring in the beautiful Milan, Italy!
We’ve joined the Australian delegation alongside some of our official partners like Avion Medical (CRO).

#bioeurope #bioeuropespring #clinicaltrials #medicalsaas #cro #pharma #asx #biotech #medtech #ai #aiinmedicine

Watch today's webinar 'Empowering Prescribers: Navigating Medicinal Cannabis': youtu.be/PgRw_Cvev_U

Speakers Damon Rasheed (CTO, Opyl) and Gillian Alexis (Founder, Phenix Health) discussed how prescribers face significant challenges when assessing medicinal cannabis treatments
#medicalcannabis

Opyl and Biointelect are hosting a webinar on ‘Enhancing Clinical Trials: From Strategy to Execution’. The discussion will cover AI-powered tools, trial planning, and global regulatory alignment.
When: 9am 9th April 2025 AEDT
www.linkedin.com/events/enhan...

#asx #biotech #clinicaltrial #investing

Executive Chairman of Opyl joined the Geeks Of The Valley podcast, a series that connects with industry leaders to discuss emerging trends in venture capital, private equity, and innovation.

Listen here: open.spotify.com/episode/1iS9... #biotech #asx

We’re excited to announce a strategic partnership with Avion, a leading full-service CRO, to bring TrialKey's AI-powered insights to clinical trial design and execution. #asx #biotech #biotechnews #biotechinvestment #biotechinvesting #asxnews

YouTube video by TrialKeyAI The Strategic Advantage of Expert CRO Partnerships

Opyl hosted a webinar “The Strategic Advantage of Expert CRO Partnerships", featuring A/Prof Tina Soulis from Alithia Life Sciences, Dr Minh-Thu Cao Xuan from Opyl, and moderated by Bernice Averion, Head of Marketing and Communications at Opyl.

Watch now: youtu.be/vFRhuEVp7FI
#pharma #ai #biotech

Join Us for a webinar on ‘The Strategic Advantage of Expert CRO Partnerships’ featuring Opyl and Alithia Life Sciences.

Date & Time: 9am AEDT, February 4th, 2025
Where: us02web.zoom.us/j/82120061173

#cro #clinicaltrials #biotech #medicalresearch #ai #drugdiscovery #clinicalresearch

Dr Minh-Thu Cao Xuan will proudly represent team Opyl at BIO-Europe Spring 2025, taking place from March 17–19 in Milan, Italy. enquire about our FREE Preliminary Reports, visit appt.link/minhthu #BIOEuropeSpring #opyl #trialkey #biotech #BIO #biopharma #clinicaltrials

This webinar features the esteemed Associate Professor A/Prof Tina Soulis from Alithia Life Sciences and Dr Minh-Thu Cao Xuan from Opyl.
Date & Time: 9am AEDT, February 4th, 2025
Where: us02web.zoom.us/s/82120061173

#asx #biotech #cro #pharma #ai #drugdiscovery #clinicaltrials #medicalresearch

A great kick-off to JP Morgan Healthcare Week! Opyl attended the Global Vic’s Welcome Reception in San Francisco to network with Australian and US senior executives in healthcare.

#biotech #medtech #opyl #trialkey #globalvic #jpmorganhealthcareweek #healthcare

Opyl Signs Landmark Binding Joint Venture with X Firm Ltd. Funding Raise: AUD $4.7–$7.8M. OPL earns AUD $1.5M license fee & 20-40% JV revenue share, focusing on APAC while JV targets US, EMEA & Africa. #asx #opl #biotech

Simulate for success! TrialKey runs each trial up to 100,000 times, achieving 92% accuracy in phase predictions and identifying key success factors. Make confident, data-driven decisions and minimise risks.

See it in action: appt.link/minhthu

#medtech #healthtech

Listen as host Shikha Jain, MD, speaks with Opyl's Damon Rasheed about using AI/LM to better predict clinical trial outcomes, handling ethical concerns surrounding AI in healthcare and more open.spotify.com/episode/4zz9... #biotech #ai #clinicaltrials #pharma #oncology #cancer #ml

Quality matters in medicinal cannabis research. With Phenix Health’s Compendium, TrialKey provides AI-reviewed validations on 900+ cannabinoid products, supporting informed decisions for chronic pain, mental health, and more.

Try a demo: appt.link/minhthu

#ai #trialkey #clinicalinsights

Precision data, powered by NLP. TrialKey uses NLP to bridge data gaps, linking insights from similar trials and building a complete model for your study. Discover precision-driven trial planning.

Book a demo today: appt.link/minhthu

#clinicaltrials #nlp #datascience

Explainable AI for actionable insights! TrialKey goes beyond data analysis to uncover true drivers of trial success. Empowered with insights, your team can make confident decisions.

Book a demo today: appt.link/minhthu

#clinicaltrials #explainableai #medtech

Elevate your proposal game with TrialKey! CROs benefit from an AI-driven preliminary report featuring competitor benchmarking & visual insights. Secure your edge in trial execution.

Book a demo: appt.link/minhthu

#cro #clinicalresearch #trialoptimisation #trialkey

We’re #Hiring: Data Scientist!

Why join:
✔️ Work on groundbreaking projects
✔️ Solve complex challenges in data analysis, M/L, and visualisation.
✔️ Solid growth trajectory and a meaningful mission.
​✔️ Flexible, remote-friendly (Sydney hours required).
​Apply now: www.linkedin.com/jobs/view/40...

markets.businessinsider.com/news/stocks/...

We’re excited to announce a strategic partnership with NeuOrphan Pty Ltd, a biotech innovator developing therapies for neurological disorders like multiple sclerosis using NeuOrphan’s drug candidate, Dioprotectome™.

#biotech #pharma #clinicaltrials #multipleclerosis

We’ve teamed up with L39 Capital to launch the world's first AI Biotech Investment Fund.
With AUD $100M in FUM targeted over 3 years across AU and US.
If you wish to participate, please email info@aibiotechfund.com or visit aibiotechfund.com and fill in the Interest Form.

Dr Minh-Thu Cao Xuan will be heading to the J.P. Morgan Healthcare Conference! Don’t miss your chance to connect with Minh-Thu! Book a meeting through the BIO 1:1 partnering app. Meet earlier via appt.link/minhthu

#clinicaltrials #jpmorgan #lifesciences #biotech #pharma #jphealthcareconference

TrialKey forecasts duration, patient dropout, and adverse events to give you a complete trial analysis. Avoid costly amendments and make informed decisions.

Book a demo today: appt.link/minhthu

#clinicaltrials #datadrivendecisions #trialanalytics #medtech #clinicalsuccess #healthinnovation

Why settle for uncertainty? TrialKey simulates trials up to 100,000 times, providing insights on outcomes, risks, and success factors. Make data-driven decisions that drive trial success.

Book a demo: appt.link/minhthu

#clinicalprecision #trialsimulation #medtech